Abstract
Randomized controlled trials are the gold standard for the evaluation of new therapies and surgical procedures and as such require strict attention to study design and statistical analysis. There are, however, multiple challenges in conducting a well-designed clinical trial. This article describes the difficulties encountered at a single institution participating in a multicenter drug study and reviews the challenges involved in developing a high-quality randomized controlled study.
Publication types
-
Clinical Trial
-
Clinical Trial, Phase III
-
Comparative Study
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Acetaminophen / therapeutic use
-
Adolescent
-
Adult
-
Aged
-
Analgesics / therapeutic use*
-
Cholecystectomy, Laparoscopic / adverse effects
-
Clinical Trials, Phase III as Topic / standards*
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / therapeutic use
-
Drug Combinations
-
Humans
-
Hydrocodone / therapeutic use
-
Informed Consent / standards
-
Isoenzymes / antagonists & inhibitors
-
Membrane Proteins
-
Middle Aged
-
Multicenter Studies as Topic / standards*
-
Pain, Postoperative / drug therapy*
-
Pain, Postoperative / etiology
-
Patient Selection
-
Prostaglandin-Endoperoxide Synthases
-
Randomized Controlled Trials as Topic / standards*
Substances
-
Analgesics
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Drug Combinations
-
Isoenzymes
-
Membrane Proteins
-
Acetaminophen
-
Hydrocodone
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases